Schedule 13D ownership disclosure

Castle Biosciences Inc

Security class unavailable · CUSIP: 14843C105

Event date: 2020-06-22

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,233,577
Percent of class
7.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-076210
Form type
SC 13D/A
Filer
CASTLE BIOSCIENCES INC
CIK
CIK 1447362
Filed
Jun 24, 2020
Reporting period
Jun 22, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub